Wellness App for Sleep Disturbance in Hematological Cancer Patients

Major Program
Supportive Care and Symptom Management
Sponsor
The University of Texas Health Science Center at San Antonio
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05294991
In a randomized controlled trial (RCT), the investigators will recruit participants to an 8-week "app-based wellness" intervention, followed by a 12-week follow-up period. The investigators will recruit a total of 276 self-declared Chronic Hematological Cancer (CHC) patients who (representative of age, race/ethnicity, and gender) will be on stable CHC pharmacologic therapy (if any), self-identify as sleep disturbed (>5 on Pittsburgh Sleep Quality Index), do not have a sleep disorder diagnosis, do not take sleep medication/supplements >3 times per week, and are not currently practicing regular meditation.

Aim 1: Test the efficacy of two app-based wellness programs (10 minutes per day) on the primary outcome of self reported sleep disturbance (Insomnia Severity Index (primary) and PROMIS Sleep Disturbance (secondary)) and secondary sleep outcomes including sleep impairment (PROMIS Sleep Impairment Scale) and sleep efficiency measured via sleep diaries and actigraphy.

Aim 2: Test the efficacy of two app-based wellness programs (10 minutes per day) on inflammatory markers (i.e., TNF-a, IL-6, IL-8, CRP), fatigue, and emotional distress (i.e., anxiety, depressive symptoms measured with PROMIS®).

Aim 3: Explore the sustained effects (i.e., 20 weeks from baseline) of two app-based wellness programs (10 minutes per day) in CHC patients.
Intervention
Wellness app intervention #1, Wellness app intervention #2
Condition
Cancer, Sleep Disturbance, Anxiety, Depression, Inflammation, Fatigue
Investigators
Jennifer Huberty, PhD, Supreet Kaur, MD, Jillian Johnson, PhD

See list of participating sites